Stock Events

Quest Diagnostics 

€137.3
173
+€0.3+0.22% Today

Statistics

Day High
137.3
Day Low
137.3
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
17.47B
P/E Ratio
21.18
Dividend Yield
2%
Dividend
2.74

Upcoming

Dividends

2%Dividend Yield
10Y Growth
8.66%
5Y Growth
6.9%
3Y Growth
6.94%
1Y Growth
6.09%

Earnings

22OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
1.86
2.02
2.19
2.35
Expected EPS
2.280225
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QDI.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap19.3B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap194.5B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap3.15B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Exact Sciences
EXAS
Mkt Cap11.4B
Exact Sciences Corporation is known for its non-invasive screening test for colorectal cancer, competing in the diagnostics market.
Neogenomics
NEO
Mkt Cap2.12B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap2.57B
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

Analyst Ratings

156.56Average Price Target
The highest estimate is €165.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
22%
Hold
78%
Sell
0%

About

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
CEO
Mr. James E. Davis
Employees
50000
Country
US
ISIN
US74834L1008
WKN
000904533

Listings